Clostridium-DTDB: A comprehensive database for potential drug targets of Clostridium difficile

Computers in Biology and Medicine

Volumn 43, Issue 4, 2013, Pages 362-367

  Jadhav, Ankush ^a   Ezhilarasan, Vijayalakshmi ^a   Prakash Sharma, Om ^a   Pan, Archana ^a  

^a PONDICHERRY UNIVERSITY   (India)

Author keywords

Choke point analysis; Clostridium; Database; Drug targets; Homology modeling

Indexed keywords

BIOINFORMATICS TOOLS; CHOKE POINTS; CLOSTRIDIUM DIFFICILE; DRUG TARGETS; HOMOLOGY MODELING; POTENTIAL DRUG TARGETS; STRUCTURAL INFORMATION; THREE-DIMENSIONAL STRUCTURE;

BIOINFORMATICS; DATABASE SYSTEMS; HEALTH CARE; STRAIN;

CLOSTRIDIUM;

CLOSTRIDIUM DIFFICILE TOXIN B;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG TARGETING; ESSENTIAL GENE; METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRUCTURAL GENOMICS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENOMICS; INTERNET; INTESTINES; TECHNOLOGY, PHARMACEUTICAL; USER-COMPUTER INTERFACE;

CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE;

EID: 84875373780     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2013.01.009     Document Type: Article

References (41)

1. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7:526-536.
2. Adalja A.A., Kellum J.A. Clostridium difficile: moving beyond antimicrobial therapy. Crit. Care 2010, 14:320.
3. Garey K.W., Sethi S., Yadav Y., DuPont H.L. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J. Hosp. Infect. 2008, 70:298-304.
4. Gerding D.N., Muto C.A., Owens R.C. Treatment of Clostridium difficile infection. Clin. Infect. Dis. 2008, 48:S32-S42.
5. Allsop A.E. Bacterial genome sequencing and drug discovery. Curr. Opin. Biotechnol. 1998, 9:637-642.
6. Singh S., Joshi P., Chopade B.A. Choke point analysis of the metabolic pathways of Acinetobacter baylyi: a genomics approach to assess potential drug targets. J. Bioinfom. Sequence Anal. 2009, 1:41-45.
7. Singh S., Malik B.K., Sharma D.K. Choke point analysis of metabolic pathways in E. histolytica: a computational approach for drug target identification. Bioinformation 2007, 2:68-72.
8. Madagi S., Patil V.M., Sadegh S., Singh A.K., Garwal B., Banerjee A., Talambedu U., Bhattacharjee B. Identification of membrane associated drug targets in Borrelia burgdorferi ZS7-subtractive genomics approach. Bioinformtaion 2011, 6:356-359.
9. Galperin M.Y., Koonin E.V. Searching for drug targets in microbial genomes. Curr. Opin. Biotechnol. 1999, 10:571-578.
10. Butt A.M., Tahir S., Nasrullah I., Idrees M., Lu J., Tong Y. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. Infect. Genet. Evol. 2012, 12:53-62.
11. Anishetty S., Pulimi M., Pennathur G. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput. Biol. Chem. 2005, 29:368-378.
12. Morya V.K., Dewaker V., Mecarty S.D., Singh R. In silico analysis metabolic pathway for identification of putative drug targets for Staphylococcus aureus. J. Comput. Sci. Syst. Biol. 2010, 3:62-69.
13. Sharma A., Pan A. Identification of potential drug targets in Yersinia pestis using metabolic pathway analysis: MurE ligase as a case study. Eur. J. Med. Chem. 2012, 57:185-195.
14. Dutta A., Singh S.K., Ghosh P., Mukherjee R., Mitter S., Bandyopadhyay D. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol. 2006, 6:43-47.
15. Sarkar M., Maganti L., Ghoshal N., Dutta C. In silico quest for putative drug tarets in Helicobacter pylori HPAG1: molecular modeling of candidate enzymes from lipopolysaccharide biosynthesis pathway. J. Mol. Model. 2012, 18:1855-1866.
16. Sayers E.W., Barrett T., Benson D.A., Bryant S.H., Canese K., Chetvernin V., Church D.M., DiCuccio M., Edgar R., Federhen S., Feolo M., Geer L.Y., Helmberg W., Kapustin Y., Landsman D., Lipman D.J., Madden T.L., Maglott D.R., Miller V., Mizrachi I., Ostell J., Pruitt K.D., Schuler G.D., Sequeira E., Sherry S.T., Shumway M., Sirotkin K., Souvorov A., Starchenko G., Tatusova T.A., Wagner L., Yaschenko E., Ye J. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2009, 37. D5-15.
17. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
18. Raman K., Yeturu K., Chandra N. TargetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst. Biol. 2008, 2:109-130.
19. Zhang R., Ou H.Y., Zhang C.T. DEG: a database of essential genes. Nucleic Acids Res. 2004, 32:D271-D272.
20. Li Li, Stoeckert C.J., Roos D.S. OrthoMCL: Identification of orthologous groups for eukaryotic genomes. Genome Res. 2003, 13:2178-2189.
21. Chen F., Mackey A.J., Stoeckert C.J., Roos D.S. OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res. 2006, 34:D363-D368.
22. Fischer S., Brunk B.P., Chen F., Gao X., Harb O.S., Iodice J.B., Shanmugam D., Roos D.S., Stoeckert C.J. Using OrthoMCL to assign proteins to OrthoMCL-DB groups or to cluster proteomes into new ortholog groups. Curr. Protoc. Bioinform. 2011, 35:1-19.
23. Tatusov R.L., Galperin M.Y., Natale D.A., Koonin E.V. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res. 2000, 28:33-36.
24. Kaufimann M. The role of the COG database in comparative and functional genomics. Curr. Bioinform. 2006, 1:291-300.
25. Rahaman S.A., Schomburg D. Observing local and global properties of metabolic pathways: 'load point' and 'choke points' in the metabolic networks. Bioinformatics 2006, 22:1767-1774.
26. Yeh I., Hanekamp T., Tsoka S., Karp P.D., Altman R.B. Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res. 2004, 14:917-924.
27. Karp P.D., Paley S., Romero P. The pathway tools software. Boinformatics 2002, 18:S225-S232.
28. Jacobs D.M., Gaudier E., Van Duynhoven J., Vaughan E.E. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr. Drug Metab. 2009, 10:41-54.
29. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32:D277-D280.
30. Fiser A., Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol. 2003, 374:461-491.
31. Wiederstein M., Sippl M.J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007, 35:W407-W410.
32. Bernstein F.C., Koetzle T.F., Williams G.J.B., Meyer E.F., Brice M.D., Rogers J.R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 1977, 112:535-542.
33. Laskowski R.A., Macarthur M.W., Moss D.S., Thornton J.M. Procheck: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 1993, 26:283-291.
34. Ramachandran G.N., Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 1968, 23:283-438.
35. Eisenberg D., Luthy R., Bowie J.U. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 1997, 277:396-404.
36. Colovos C., Yeates T.O. Verification of protein structures: patterns of non-bonded atomic interactions. Protein Sci. 1993, 2:1511-1519.
37. Sharma O.P., Jadhav A., Hussain A., Kumar M.S. VPDB: Viral Protein Structural Database. Bioinformation 2011, 6:324-326.
38. Sharma O.P., Pan A., Hoti S.L., Jadhav A., Kannan M., Mathur P.P. Modeling, docking, simulation, and inhibitory activity of the benzimidazole analogue against b-tubulin protein from Brugia malayi for treating lymphatic filariasis. Med. Chem. Res. 2012, 21:2415-2427.
39. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev. Biophys. Biomol. Struct. 2000, 29:291-325.
40. Hussain M., Kumar S., Subbarao N., Pandey H.P., Singh D.V. Homology modeling of a sensor histidine kinase from Aeromonas hydrophila. J. Mol. Model. 2010, 16:1003-1009.
41. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem. Mol. Biol. Educ. 2006, 34:255-261.